Processes of making and crystalline forms of a mdm2 inhibitor
US-2025295647-A1 · Sep 25, 2025 · US
This page is not indexed by search engines while we improve data quality.
Bio Matthew patents
Bio Matthew is listed as an inventor on 23 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Bio Matthew |
| Total patents | 23 |
| First publication | May 21, 2015 |
| Latest publication | Sep 25, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Processes of making and crystalline forms of a mdm2 inhibitor
US-2023301974-A1 · Sep 28, 2023 · US
Processes of making and crystalline forms of a mdm2 inhibitor
US-2022280496-A1 · Sep 8, 2022 · US
Processes of making and crystalline forms of a mdm2 inhibitor
US-2020281912-A1 · Sep 10, 2020 · US
Polymorphic forms and co-crystals of a c-Met inhibitor
US-10344041-B2 · Jul 9, 2019 · US
Polymorphic forms and co-crystals of a c-met inhibitor
US-2018244696-A1 · Aug 30, 2018 · US
Crystalline forms of N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine salts and uses thereof
US-10053452-B2 · Aug 21, 2018 · US
Polymorphic forms and co-crystals of a c-Met inhibitor
US-9981988-B2 · May 29, 2018 · US
Processes of making and crystalline forms of a mdm2 inhibitor
US-2018092898-A1 · Apr 5, 2018 · US
Processes of making and crystalline forms of a MDM2 inhibitor
US-9855259-B2 · Jan 2, 2018 · US
Recent patents
Latest publications not already listed above.
Processes of making and crystalline forms of a MDM2 inhibitor
US-9801867-B2 · Oct 31, 2017 · US
Method for the preparation of [1,2,4]-triazolo[4,3-a]pyridines
US-9643984-B2 · May 9, 2017 · US
Processes of making and crystalline forms of a MDM2 inhibitor
US-9623018-B2 · Apr 18, 2017 · US
Polymorphic forms and co-crystals of a c-met inhibitor
US-2017029443-A1 · Feb 2, 2017 · US
Method for the preparation of [1,2,4]-triazolo[4,3-a]pyridines
US-2016347769-A1 · Dec 1, 2016 · US
Crystalline forms of n-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl -2-thienyl)-1-phthalazinamine salts and uses thereof
US-2016304504-A1 · Oct 20, 2016 · US
Processes of making and crystalline forms of a mdm2 inhibitor
US-2016289190-A1 · Oct 6, 2016 · US
Processes of making and crystalline forms of a mdm2 inhibitor
US-2016289243-A1 · Oct 6, 2016 · US
Processes of making and crystalline forms of a mdm2 inhibitor
US-2016287570-A1 · Oct 6, 2016 · US
Processes of making and crystalline forms of a mdm2 inhibitor
US-2016264526-A1 · Sep 15, 2016 · US
Processes of making and crystalline forms of a MDM2 inhibitor
US-9376386-B2 · Jun 28, 2016 · US
Method for the preparation of thiadiazoles
US-9296735-B2 · Mar 29, 2016 · US
Method for the preparation of thiadiazoles
US-2015141655-A1 · May 21, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Amgen Inc | 26 |
| Amgen Iinc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07B2200/13 | 19 |
| A61P35/00 | 18 |
| C07C309/04 | 15 |
| A61P35/02 | 14 |
| C07D211/76 | 13 |